Basis: FMP quote market capitalization / four-quarter operating cash flow less absolute capital expenditures. Source: stored company filings and market data; unavailable inputs remain N/A.
The Price/FCF ratio is N/A as of 2026-10-06T17:36:34.115Z.
Calculation as of: 2026-10-06T17:36:34.115Z.
Quote observation: 2026-10-06T17:34:58.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 0fde8dae4c5ae63ee7b35c7e6e46bba2fdf5d6d5db310b32cf0eb41a7e17e840
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PRICE/FCF RATIO
N/A
Market Cap
$137.11M
Price/FCF Ratio
520.40
TTM Avg
1083.05
3Y Avg
1083.05
5Y Avg
1083.05
Market Cap
$132.98M
Price/FCF Ratio
174.97
TTM Avg
111.34
3Y Avg
100.72
5Y Avg
72.71
Market Cap
$132.64M
Price/FCF Ratio
10.16
TTM Avg
13.06
3Y Avg
13.06
5Y Avg
13.06
| NAME | MARKET CAP | PRICE/FCF RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Freenome, Inc. (FRNM) | $135.12M | N/A | N/A | N/A | N/A |
| Atrium Therapeutics, Inc. (RNA)vs › | $135.65M | N/A | N/A | N/A | N/A |
| Organigram Global Inc. (OGI)vs › | $134.10M | N/A | N/A | N/A | N/A |
| LifeMD, Inc. (LFMD)vs › | $133.72M | N/A | 63.37 | 576.34 | 569.67 |
| KORU Medical Systems, Inc. (KRMD)vs › | $137.11M | 520.40 | 1083.05 | 1083.05 | 1083.05 |
| AirSculpt Technologies, Inc. (AIRS)vs › | $132.98M | 174.97 | 111.34 | 100.72 | 72.71 |
| Health Catalyst, Inc. (HCAT)vs › | $132.64M | 10.16 | 13.06 | 13.06 | 13.06 |
| Alpha Cognition Inc (ACOG)vs › | $137.92M | N/A | N/A | N/A | N/A |
| Pyxis Oncology, Inc. (PYXS)vs › | $130.75M | N/A | N/A | N/A | N/A |
| Fortress Biotech, Inc. (FBIOP)vs › | $139.73M | 1.11 | 4.90 | 4.90 | 4.90 |
P/FCF Ratio
N/A
FCF Yield
N/A
P/FCF measures market price relative to free cash flow per share. Free cash flow is operating cash flow after capital expenditures.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
